Exercise study for early-stage triple-negative breast cancer patients
Part of Cancer clinical trials.
This study tests if aerobic exercise can help women and men with stage 2 or 3 triple-negative breast cancer who are getting chemotherapy and immunotherapy before surgery. It aims to see if exercise improves treatment outcomes and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older with stage 2 or 3 triple-negative breast cancer.
- You need to be able to walk without help and march in place for 30 seconds.
- You should be planned to receive a specific chemotherapy and immunotherapy combination before surgery.
- You must get permission from your medical oncologist to join.
- You need to be able to read and understand study instructions in English.
- You should not have any health condition or medication that makes exercise unsafe or affects your immune function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of an immunotherapy drug (pembrolizumab) plus two chemotherapy drugs (carboplatin and paclitaxel) given before surgery for people with early-stage, triple-negative breast cancer. The goal is to see if this treatment helps shrink or eliminate the tumor before it's removed.
This trial tests whether using blood tests and imaging during chemotherapy and immunotherapy can help guide treatment for early-stage triple-negative breast cancer. It aims to improve outcomes by adjusting treatment based on how the cancer responds.
This study tests whether an exercise program can help women with triple-negative breast cancer during their chemotherapy treatment. You will be asked to participate in a supervised exercise routine while receiving your standard cancer drugs.
This trial tests whether a structured exercise program can help women with newly diagnosed triple-negative breast cancer who are getting a specific combination of immunotherapy and chemotherapy. The goal is to see if staying active during treatment improves outcomes and well-being.
This trial tests whether a structured lifestyle program (diet and exercise) can make standard chemotherapy before surgery work better for triple-negative breast cancer. It looks at how the program affects your body’s response to treatment and your overall health.
This study looks at whether a program of healthy eating and exercise, started during chemotherapy, can help shrink your tumor more effectively. You will be randomly assigned to either follow the diet and exercise plan or stick with your usual care.
Hear when a new Aerobic Exercise trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.